Brazil · Delayed Price · Currency is BRL Bradsaúde Statistics
Total Valuation
Bradsaúde has a market cap or net worth of BRL 42.68 billion. The enterprise value is 42.83 billion.
| Market Cap | 42.68B |
| Enterprise Value | 42.83B |
Important Dates
The next confirmed earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jul 1, 2026 |
Share Statistics
Bradsaúde has 2.92 billion shares outstanding. The number of shares has increased by 62.64% in one year.
| Current Share Class | 2.92B |
| Shares Outstanding | 2.92B |
| Shares Change (YoY) | +62.64% |
| Shares Change (QoQ) | +436.32% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.53% |
| Float | 252.88M |
Valuation Ratios
The trailing PE ratio is 12.26 and the forward PE ratio is 8.88. Bradsaúde's PEG ratio is 1.21.
| PE Ratio | 12.26 |
| Forward PE | 8.88 |
| PS Ratio | 3.99 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | 67.30 |
| P/OCF Ratio | 66.03 |
| PEG Ratio | 1.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.12, with an EV/FCF ratio of 67.52.
| EV / Earnings | 40.63 |
| EV / Sales | 4.01 |
| EV / EBITDA | 23.12 |
| EV / EBIT | 23.13 |
| EV / FCF | 67.52 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.07 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.32 |
| Interest Coverage | 5.03 |
Financial Efficiency
Return on equity (ROE) is 10.54% and return on invested capital (ROIC) is 12.75%.
| Return on Equity (ROE) | 10.54% |
| Return on Assets (ROA) | 5.03% |
| Return on Invested Capital (ROIC) | 12.75% |
| Return on Capital Employed (ROCE) | 6.55% |
| Weighted Average Cost of Capital (WACC) | 7.38% |
| Revenue Per Employee | 5.46M |
| Profits Per Employee | 538,577 |
| Employee Count | 1,957 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3,419.12 |
Taxes
In the past 12 months, Bradsaúde has paid 378.35 million in taxes.
| Income Tax | 378.35M |
| Effective Tax Rate | 26.42% |
Stock Price Statistics
The stock price has increased by +14.52% in the last 52 weeks. The beta is 0.46, so Bradsaúde's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +14.52% |
| 50-Day Moving Average | 14.60 |
| 200-Day Moving Average | 13.33 |
| Relative Strength Index (RSI) | 65.82 |
| Average Volume (20 Days) | 6,064,815 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bradsaúde had revenue of BRL 10.68 billion and earned 1.05 billion in profits. Earnings per share was 1.19.
| Revenue | 10.68B |
| Gross Profit | 3.14B |
| Operating Income | 1.76B |
| Pretax Income | 1.43B |
| Net Income | 1.05B |
| EBITDA | 1.75B |
| EBIT | 1.76B |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 13.19 billion in cash and 204.83 million in debt, with a net cash position of -143.59 million or -0.05 per share.
| Cash & Cash Equivalents | 13.19B |
| Total Debt | 204.83M |
| Net Cash | -143.59M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 18.71B |
| Book Value Per Share | 6.40 |
| Working Capital | 964.17M |
Cash Flow
In the last 12 months, operating cash flow was 646.46 million and capital expenditures -12.20 million, giving a free cash flow of 634.26 million.
| Operating Cash Flow | 646.46M |
| Capital Expenditures | -12.20M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -17.62M |
| Free Cash Flow | 634.26M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 29.36%, with operating and profit margins of 16.52% and 9.87%.
| Gross Margin | 29.36% |
| Operating Margin | 16.52% |
| Pretax Margin | 13.40% |
| Profit Margin | 9.87% |
| EBITDA Margin | 16.41% |
| EBIT Margin | 16.52% |
| FCF Margin | 5.94% |
Dividends & Yields
This stock pays an annual dividend of 0.81, which amounts to a dividend yield of 5.49%.
| Dividend Per Share | 0.81 |
| Dividend Yield | 5.49% |
| Dividend Growth (YoY) | -63.66% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.20% |
| Buyback Yield | -62.64% |
| Shareholder Yield | -57.15% |
| Earnings Yield | 2.47% |
| FCF Yield | 1.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Bradsaúde is 17.77, which is 14.65% higher than the current price. The consensus rating is "Buy".
| Price Target | 17.77 |
| Price Target Difference | 14.65% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 188.25% |
| EPS Growth Forecast (3Y) | 17.74% |
Stock Splits
The last stock split was on April 5, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |